Competition

  • July 23, 2026

    NCAA Appeals Ohio Judge's Block On Athletes' Eligibility

    The NCAA has appealed an Ohio state judge's decision that permitted 24 college basketball players to play in the upcoming season while they challenge the organization's eligibility restrictions.

  • July 23, 2026

    Another Landlord Exits Kentucky's RealPage Antitrust Case

    Kentucky has settled antitrust claims with another landlord that it had accused of using RealPage's revenue management software for rent price-fixing.

  • July 23, 2026

    Crowell & Moring Adds Former UBS Bank USA GC

    Crowell & Moring LLP hired a former general counsel for UBS Bank USA this week to advise banks, fintechs and digital assets companies on regulatory matters.

  • July 23, 2026

    CMA Seeks Views On Sky's £1.6B Buy Of ITV Broadcast Arm

    The U.K. antitrust watchdog said Thursday that it has called for comments on how media giant Sky Group's planned £1.6 billion ($2.1 billion) acquisition of an ITV division could affect competition in Britain.

  • July 23, 2026

    Google Fined €890M By EU For Restricting Competition

    The European Union fined Google owner Alphabet Inc. a total of €890 million ($1.04 billion) on Thursday after finding that the U.S. technology giant unfairly favored its own services in search results and restricted app developers from directing users to cheaper options.

  • July 22, 2026

    Deckers Wants New IP Validity Trial Over 'Fundamental' Error

    Deckers Outdoor Corp. on Wednesday moved for a new trial on the validity of its design patent for its Ugg Classic Ultra Mini Boot, saying it was a "fundamental legal error" for the court to instruct the jury that it could invalidate the patent for indefiniteness.

  • July 22, 2026

    Late Emails Undercut BCBS Pricing Suit, Walgreens Says

    Walgreen Co. is urging an Illinois federal judge to again sanction a Blue Cross Blue Shield insurer and its subsidiary for allegedly failing to produce key email evidence the pharmacy retailer says "upends" the insurers' 6-year-old claim that it intentionally overcharged them for prescription drugs.

  • July 22, 2026

    House Republicans Urge Fed To Speed Up Bank M&A Reviews

    Republicans on the House Financial Services Committee are calling on the Federal Reserve to explore what else can be done to speed up its bank merger reviews, urging it to look into clearing long-delayed applications and allowing more approvals without a board vote.

  • July 22, 2026

    Writers Guild Wants Paramount-Warner Bros. Block Extended

    The Writers Guild of America asked a California federal judge Wednesday to extend the two-week injunction against Paramount Skydance's proposed $110 billion acquisition of Warner Bros. Discovery, warning that permitting the deal to close while challenges proceed would allow the companies to shut down projects and share negotiation information.

  • July 22, 2026

    Nexstar Execs On Tegna Board Violates Injunction, Judge Told

    DirecTV and a coalition of states told a California federal court on Wednesday that Nexstar Media Group has taken over Tegna's board of directors, despite a preliminary injunction preventing the broadcasting companies from fully integrating.

  • July 22, 2026

    UFC Wants Pay-Per-View Monopolizing Case Tossed

    Ultimate Fighting Championship is asking the district court in Nevada to toss out a proposed class action filed by fans accusing it of monopolizing the market for pay-per-view mixed martial arts events.

  • July 22, 2026

    Safety-Net Clinics Defend Insulin Suit Revival To Justices

    Safety-net healthcare providers urged the U.S. Supreme Court not to take on the revival of their proposed antitrust class action against Sanofi-Aventis, Eli Lilly, Novo Nordisk and AstraZeneca, arguing Wednesday that the Second Circuit's decision was based on neither mere trade group lobbying nor any kind of overcharge.

  • July 22, 2026

    MillerKnoll Wins $172K Fees After Beating Bubble Lamp IP Suit

    A Michigan federal judge on Wednesday awarded MillerKnoll $172,000 in attorney fees after it defeated intellectual property claims brought by the heirs of modernist furniture designer George Nelson over his iconic bubble lamps, in a case with purportedly tens of millions of dollars at stake.

  • July 22, 2026

    Altria, Juul Ask 9th Circ. To Nix Antitrust Classes

    Altria and Juul are urging the Ninth Circuit to undo a class certification ruling in an antitrust case over Altria's past investment in the e-cigarette maker, saying the classes include disparate groups of purchasers from across the country.

  • July 22, 2026

    States Say Nielsen Ruling Backs Claims In Live Nation Suit

    A recent Second Circuit ruling in a data-tying case was invoked Wednesday to support a motion by more than a dozen state attorneys general opposing Live Nation's attempt to overturn a federal jury verdict against the company.

  • July 22, 2026

    World Cup Brand Battles Will Outlast Spain's Title Victory

    The 2026 FIFA World Cup came to an end Sunday with Spain winning for the second time in its history, but intellectual property battles are just heating up as companies and individuals seek to capitalize on the global event, experts told Law360.

  • July 22, 2026

    AGs Appeal Order Blocking RealPage Damages In MDL

    Attorneys general for Kentucky, Washington state, New Jersey, Maryland and D.C. have asked the Sixth Circuit to review a district court ruling barring them from seeking damages on behalf of their residents alongside private plaintiffs' settlements in a sweeping multidistrict litigation accusing landlords of using RealPage software to collude on rent prices.

  • July 22, 2026

    Apple Says Tech Co.'s US Action Undercuts Wireless Fee Deal

    Apple has urged an Israeli tech company to abandon U.S. litigation over a royalties dispute for wireless charging patents, saying the case is no longer necessary because the companies agreed to negotiate new licensing terms in the U.K.

  • July 22, 2026

    CMA Launches Review Of McCormick's $45B Unilever Deal

    The competition watchdog has launched a review into the proposed $44.8 billion acquisition by McCormick & Co. Inc. of Unilever PLC's foods business, inviting responses before it decides whether to open a formal merger investigation.

  • July 21, 2026

    Trump Nominates FCC's Top Atty For DOJ Antitrust Chief

    President Donald Trump on Tuesday officially nominated the Federal Communications Commission's general counsel to serve as the top antitrust official in the U.S. Department of Justice.

  • July 21, 2026

    Settlement Admins, Banks, Fintechs Target Conspiracy MDL

    Two banks, three prepaid card companies and four major class action settlement administrators asked a D.C. federal judge to dismiss the consolidated proposed class action accusing them of a wide-ranging kickback scheme juicing administration fees while diminishing class action payouts.

  • July 21, 2026

    India-Based AI Founder Says Colo. Court Lacks Jurisdiction

    The former chief business officer and founder of an AI mapping company accused of copying thousands of its rivals' maps told a Colorado federal judge Monday that the court has no jurisdiction over him and that the claims against him must be dismissed.

  • July 21, 2026

    Google's Copyright Claims Over Scraping Tossed, For Now

    A California federal judge has dismissed Google's complaint accusing data-scraping company SerpApi of bypassing technological safeguards to copy and resell the tech giant's search results, ruling that Google did not plausibly allege its anti-scraping system operated with the authority of copyright owners whose content appeared in those results.

  • July 21, 2026

    States Dispute Drugmakers' Bid To Toss GLP-1 Antitrust Case

    The attorneys general of Texas and Louisiana pushed back on Tuesday against a bid from Novo Nordisk and Eli Lilly to duck a specialty pharmacy's antitrust case accusing the companies of blocking competition for GLP-1 medications.

  • July 21, 2026

    Novo's False Ad Suit Against Eli Lilly Ramps Up GLP-1 Rivalry

    Pharmaceutical giant Novo Nordisk Inc. slapped rival Eli Lilly & Co. with a false advertising suit in New Jersey federal court Tuesday, calling a marketing campaign for the rival's weight loss drugs "deceptive" for "withholding critical scientific evidence" about newer GLP-1 formulations.

Expert Analysis

  • AG Watch: Ohio AG Joins State Antitrust Enforcement Trend

    Author Photo

    Amid the recent reprioritization in the federal government's competition enforcement agenda, two recent cases provide critical insight into how the Ohio attorney general will proceed in the relatively unprecedented trend of state attorneys general aggressively pursuing antitrust matters, say attorneys at BakerHostetler.

  • Series

    Being A Singer Makes Me A Better Lawyer

    Author Photo

    Before law school, I spent seven years trying to make it as a professional singer in Los Angeles, and nearly everything I learned about preparation, humility, confidence and more has followed me into my legal practice, says Jessica Caterina at Moses & Singer.

  • The Growing Antitrust Risks Of AI Pricing For Health Insurers

    Author Photo

    Attorneys at Patterson Belknap provide an overview of the increased risk of antitrust enforcement for health insurance companies using algorithmic price models, including in the form of multidistrict private litigation, new state and federal bills, and potential federal enforcement.

  • Parsing Who Gets The Track Record In A Venture Partner Split

    Author Photo

    A recent California federal court order in TEEC Angel Management v. Tsingyuan Ventures allowing Lanham Act claims to proceed confirms that the question of who gets to tell the story of a shared win is now being litigated as false advertising instead of industry professional etiquette, says Ben Dubin at VC Expert Services.

  • Trade Secret Practice Tips From The 1st Half Of 2026

    Author Photo

    Intellectual property attorneys should consider what several significant developments in 2026 thus far mean for how they protect, litigate and value trade secrets, focusing on new state noncompete bans, cases scrutinizing how plaintiffs identify trade secrets and federal rulings on damages doctrines, say attorneys at Faegre Drinker.

  • High Court Rulings Could Alter Agency Strategy For Cos.

    Author Photo

    The U.S. Supreme Court's recent decisions in Trump v. Slaughter and Trump v. Cook mark major turning points in the law of independent agencies and in how regulated companies should think about federal enforcement, rulemaking and agency-facing strategy, say attorneys at Holtzman Vogel.

  • Quantifying Damages In Product Launch Delay Allegations

    Author Photo

    In delayed generic-drug entry cases that have generated substantial settlements in recent years, damages are often measured by profits lost during the delay window, but this model can fail to account for potentially significant economic harm that occurs after that window, say analysts at Kroll.

  • 2 Microsoft Matters Could Help Shape AI Antitrust Outlook

    Author Photo

    A pending federal court case and investigation focusing on Microsoft's allegedly anticompetitive conduct in the deployment of artificial intelligence tools are testing whether antitrust law can distinguish ordinary competition to supply the AI ecosystem from conduct that distorts how that competition unfolds, says Kylie Kim at Massey & Gail.

  • Carbon Health Settlement Highlights Why Evidence Is Key

    Author Photo

    The California Attorney General's Office's first-of-its-kind settlement with Carbon Health, imposing penalties for alleged corporate practice of medicine violations, shows that friendly professional corporation challenges usually hinge not on the parties' management services agreement, but on whether the operational record matches it, says Ben Dubin at VC Expert Services.

  • Fed Autonomy Rests On Narrow Exception After Justices Rule

    Author Photo

    The U.S. Supreme Court’s recent decisions in Trump v. Cook and Trump v. Slaughter expand presidential removal power while temporarily preserving the Federal Reserve’s independence, but there is uncertainty about which of the Fed’s authorities fall within the court’s narrow monetary-policy exception, says Keith Bradley at Squire Patton.

  • Series

    Being A Magician Makes Me A Better Lawyer

    Author Photo

    The skills I've developed as a lifelong magician have translated directly into tangible benefits in the courtroom because performing magic and trying cases both live at the intersection of psychology, storytelling, timing and disciplined rehearsal, says Mark Dombroff at Fox Rothschild.

  • How Litigants Are Testing Conversion Therapy Ruling's Scope

    Author Photo

    Litigants are already using the U.S. Supreme Court’s recent Chiles v. Salazar ruling, which applied strict scrutiny to Colorado’s conversion therapy ban, to challenge laws limiting algorithmic rental pricing, artificial intelligence-based discrimination and anti-union employer speech, and courts must soon decide Chiles’ First Amendment limits, say attorneys at O'Melveny.

  • Future Of Fed Independence Shaky After Justices' Ruling

    Author Photo

    The U.S. Supreme Court's recent ruling in Trump v. Cook preserved the Federal Reserve's formal independence but could invite the president to remove board members with just modest protections, leaving the central bank's autonomy uncertain and potentially setting up fresh clashes over other agencies, says Steven Schwinn at the University of Chicago.

  • CFIUS' Mandate Misses Foreign Risk In Project Subcontracts

    Author Photo

    Recent calls for the Committee on Foreign Investment in the United States to review equity transactions like the Paramount Skydance-Warner Bros. deal miss a consequential oversight gap — CFIUS' inability to review the subcontracting layer of U.S. infrastructure projects, says Thibaut Giret at Alstef Group.

  • Looking At Drake's Diss Track Appeal Through An IP Lens

    Author Photo

    Though Drake's pending Second Circuit appeal over UMG's promotion of Kendrick Lamar's "Not Like Us" is formally about defamation, it shows that IP considerations can help identify records showing how a work traveled, which may guide courts when deciding context, says attorney Abdul Abdullahi.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here